CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
Cincinnati, Ohio, United States and 6 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Cincinnati, Ohio, United States and 83 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Cincinnati, Ohio, United States and 125 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Cincinnati, Ohio, United States and 209 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
Cincinnati, Ohio, United States and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Cincinnati, Ohio, United States and 115 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Cincinnati, Ohio, United States and 109 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Cincinnati, Ohio, United States and 67 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Cincinnati, Ohio, United States and 130 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Cincinnati, Ohio, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal